Allergy drug trial offers new hope for shrinking enlarged prostate
NCT ID NCT06689514
Summary
This early-stage study is testing whether a drug called tranilast, currently used for allergies and scars, can safely reduce prostate size in men with moderate-to-large benign prostate enlargement. Researchers will enroll 30 men aged 55-75 to receive either a low or high dose of the drug. The goal is to see if this approach can shrink the prostate and improve urinary symptoms without the sexual side effects common with current medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC HYPERTROPHY, BENIGN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Outside U.S./Canada, 200086, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai General Hospital
NOT_YET_RECRUITINGShanghai, 200086, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.